BIOMARIN PHARMACEUTICAL INC·4

May 26, 9:15 PM ET

LAWLIS V BRYAN 4

4 · BIOMARIN PHARMACEUTICAL INC · Filed May 26, 2022

Insider Transaction Report

Form 4
Period: 2022-05-24
Transactions
  • Award

    Common Stock

    [F1]
    2022-05-24+4,98028,950 total
Footnotes (1)
  • [F1]Restricted stock units granted on May 24, 2022. Price not applicable.
Signature
/s/ Eric Fleekop, Attorney-in-Fact|2022-05-26

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4